Status:
COMPLETED
Reusing Needles for Subcutaneous Insulin Injection in Patients With Type 2 Diabetes
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A randomized clinical trial (RCT) will be carried out to compare the reuse or not of needles in patients with type 2 diabetes (T2DM) that use insulin. Two groups will be studied: a group that will not...
Detailed Description
Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic disease with increasing incidence worldwide. It is well demonstrated in the literature that adequate glycemic control can reduce the incid...
Eligibility Criteria
Inclusion
- Patients with T2DM
- Over 18 years of age
- Reuses each syringe at least three times for insulin application.
Exclusion
- Use of insulin pens
- Pregnant women
- Patients undergoing chemotherapy
- Use of anticoagulants
- Clotting disorders, lesions or skin changes
Key Trial Info
Start Date :
October 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2022
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT05407233
Start Date
October 14 2019
End Date
October 10 2022
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gabriela Berlanda
Porto Alegre, Rio Grande do Sul, Brazil, 90410-000